StressCovidV1, 2020, Analysis, bibRecord, 000635

Carnosine and Lung Disease.

Identifieur interne : 000635 ( 2020/Analysis ); précédent : 000634; suivant : 000636

Carnosine and Lung Disease.

Auteurs : Ken-Ichiro Tanaka [Japon] ; Masahiro Kawahara [Japon]

Source :

Current medicinal chemistry [ 1875-533X ] ; 2020.

RBID : pubmed:31309876

Abstract

Carnosine (β-alanyl-L-histidine) is a small dipeptide with numerous activities, including antioxidant effects, metal ion chelation, proton buffering capacity, and inhibitory effects on protein carbonylation and glycation. Carnosine has been mostly studied in organs where it is abundant, including skeletal muscle, cerebral cortex, kidney, spleen, and plasma. Recently, the effect of supplementation with carnosine has been studied in organs with low levels of carnosine, such as the lung, in animal models of influenza virus or lipopolysaccharide-induced acute lung injury and pulmonary fibrosis. Among the known protective effects of carnosine, its antioxidant effect has attracted increasing attention for potential use in treating lung disease. In this review, we describe the in vitro and in vivo biological and physiological actions of carnosine. We also report our recent study and discuss the roles of carnosine or its related compounds in organs where carnosine is present in only small amounts (especially the lung) and its protective mechanisms.

DOI: 10.2174/0929867326666190712140545
PubMed: 31309876

Affiliations:

Links to Exploration step

pubmed:31309876

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Carnosine and Lung Disease.</title>
<author><name sortKey="Tanaka, Ken Ichiro" sort="Tanaka, Ken Ichiro" uniqKey="Tanaka K" first="Ken-Ichiro" last="Tanaka">Ken-Ichiro Tanaka</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kawahara, Masahiro" sort="Kawahara, Masahiro" uniqKey="Kawahara M" first="Masahiro" last="Kawahara">Masahiro Kawahara</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:31309876</idno>
<idno type="pmid">31309876</idno>
<idno type="doi">10.2174/0929867326666190712140545</idno>
<idno type="wicri:Area/PubMed/Corpus">000191</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000191</idno>
<idno type="wicri:Area/PubMed/Curation">000191</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000191</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000137</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000137</idno>
<idno type="wicri:Area/Ncbi/Merge">000A34</idno>
<idno type="wicri:Area/Ncbi/Curation">000A34</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000A34</idno>
<idno type="wicri:Area/Main/Merge">000636</idno>
<idno type="wicri:Area/Main/Curation">000635</idno>
<idno type="wicri:Area/Main/Exploration">000635</idno>
<idno type="wicri:Area/2020/Extraction">000635</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Carnosine and Lung Disease.</title>
<author><name sortKey="Tanaka, Ken Ichiro" sort="Tanaka, Ken Ichiro" uniqKey="Tanaka K" first="Ken-Ichiro" last="Tanaka">Ken-Ichiro Tanaka</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kawahara, Masahiro" sort="Kawahara, Masahiro" uniqKey="Kawahara M" first="Masahiro" last="Kawahara">Masahiro Kawahara</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Current medicinal chemistry</title>
<idno type="eISSN">1875-533X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Carnosine (β-alanyl-L-histidine) is a small dipeptide with numerous activities, including antioxidant effects, metal ion chelation, proton buffering capacity, and inhibitory effects on protein carbonylation and glycation. Carnosine has been mostly studied in organs where it is abundant, including skeletal muscle, cerebral cortex, kidney, spleen, and plasma. Recently, the effect of supplementation with carnosine has been studied in organs with low levels of carnosine, such as the lung, in animal models of influenza virus or lipopolysaccharide-induced acute lung injury and pulmonary fibrosis. Among the known protective effects of carnosine, its antioxidant effect has attracted increasing attention for potential use in treating lung disease. In this review, we describe the in vitro and in vivo biological and physiological actions of carnosine. We also report our recent study and discuss the roles of carnosine or its related compounds in organs where carnosine is present in only small amounts (especially the lung) and its protective mechanisms.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
<region><li>Région de Kantō</li>
</region>
<settlement><li>Tokyo</li>
</settlement>
</list>
<tree><country name="Japon"><region name="Région de Kantō"><name sortKey="Tanaka, Ken Ichiro" sort="Tanaka, Ken Ichiro" uniqKey="Tanaka K" first="Ken-Ichiro" last="Tanaka">Ken-Ichiro Tanaka</name>
</region>
<name sortKey="Kawahara, Masahiro" sort="Kawahara, Masahiro" uniqKey="Kawahara M" first="Masahiro" last="Kawahara">Masahiro Kawahara</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/2020/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000635 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000635 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    2020
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:31309876
   |texte=   Carnosine and Lung Disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i   -Sk "pubmed:31309876" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021

Serveur d'exploration Stress et Covid

Carnosine and Lung Disease.

Carnosine and Lung Disease.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration Stress et Covid
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.